Iradimed Corp revenue
Iradimed Corp's revenue was $83.8m in fiscal 2025, up 14.4% on the year before. Since fiscal 2013 ($11.3m) it has grown at a compound 18.1% a year. Over the last twelve months it was $89.3m.
Revenue history
| Fiscal year | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11 | 16 | 32 | 32 | 23 | 30 | 39 | 32 | 42 | 53 | 66 | 73 | 84 | 89 |
| Growth on the year before | — | +38.0% | +101.8% | +2.9% | −29.0% | +31.9% | +26.5% | −17.7% | +31.8% | +27.5% | +23.0% | +11.7% | +14.4% | — |
| Gross profit | 8 | 12 | 26 | 26 | 18 | 23 | 30 | 24 | 32 | 41 | 50 | 56 | 64 | 67 |
| Gross margin | 74.8% | 78.3% | 81.5% | 81.1% | 75.9% | 76.3% | 77.1% | 74.3% | 76.6% | 77.4% | 76.5% | 76.9% | 76.7% | 75.5% |
Where the revenue comes from
| Region | Revenue | Share | YoY |
|---|---|---|---|
| United States | $70.6M | 84.2% | ▲ 16.4% |
| Outside the US | $13.3M | 15.8% | ▲ 4.9% |
From Iradimed Corp's 10-K filed March 6, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Iradimed Corp | $89.3m | 11.0% | 12.4% |
| Pulmonx Corp | $87.4m | -3.4% | 13.0% |
| Delcath Systems, Inc. | $95.4m | 35.8% | 230.8% |
| Sight Sciences, Inc. | $83.4m | 9.3% | 0.8% |
| Tela Bio, Inc. | $79.9m | 6.1% | 17.6% |
| PRO DEX Inc | $79.6m | 13.3% | 19.2% |
Compare with peers
- Pulmonx Corp revenue
- Delcath Systems, Inc. revenue
- Sight Sciences, Inc. revenue
- Tela Bio, Inc. revenue
- PRO DEX Inc revenue
Head to head: IRMD vs LUNGDCTH vs IRMDIRMD vs SGHT
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies